{
  "id": "5e2e1d6afbd6abf43b000026",
  "type": "yesno",
  "question": "Do MAIT cells have a role in multiple myeloma?",
  "ideal_answer": "Yes, MAIT cells may represent new immunotherapeutic targets for treatment of Multiple Myeloma and other malignancies",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
    "http://www.ncbi.nlm.nih.gov/pubmed/30153633"
  ],
  "snippets": [
    {
      "text": "hus, MAIT cells are reduced in MM patients, which may contribute to disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of MM and other malignancies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we have analysed the frequency and function of MAIT cells in multiple myeloma (MM) patients. We show that MAIT cell frequency in blood is reduced compared to healthy adult donors, but comparable to elderly healthy control donors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Newly diagnosed MM patient MAIT cells had reduced IFN\u03b3 production and CD27 expression, suggesting an exhausted phenotype, although IFN\u03b3-producing capacity is restored in relapsed/refractory patient samples. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We describe recent observations with regard to functional exhaustion of iNKT and MAIT cells in MM pathology and discuss the potential application of checkpoint inhibition as an attractive target for prolonged activation of these immunomodulatory T cells in the treatment of MM.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30153633",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Thus, MAIT cells are reduced in MM patients, which may contribute to disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of MM and other malignancies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}